Unknown PHASE4 INTERVENTIONAL 2-arm NCT04389801

Use of Desferal for Prevention of ARDS in Hospitalised Cases Documented With Covid 19 Infection

The Use of Desferal and Adjuvants for Prevention of ARDS in Hospitalised Cases Documented With Covid 19 Infection: A Randomized Controlled Trial

Sponsor: Hesham Al-Inany

Conditions Covid 19

Interventions Desferal 500 MG Injection

Updated 5 times since 2020 Last updated: May 14, 2020 Started: Jun 1, 2020 Primary completion: Sep 30, 2020 Completion: Dec 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Covid 19 and is currently ongoing. Hesham Al-Inany leads this study, which shows 5 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jun 2022 — Jul 2024 [monthly]

Unknown Status PHASE4

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Jun 2022 [monthly]

Not Yet Recruiting PHASE4
Jun 2020 — Jan 2021 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hesham Al-Inany

Data source: Cairo University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.